# Oral Semaglutide Reduces Heart Failure Events in Type 2 Diabetes

**Category:** Health
**Source:** [https://www.nhms.org/news/february-2026-health-news-roundup](https://www.nhms.org/news/february-2026-health-news-roundup)
**Publisher:** New Hampshire Medical Society
**Authors:** Cj Buys
**Published:** 2/13/26
**Scraped (UTC):** 2026-02-17T02:07:54+00:00

![Article Image](https://assets-002.noviams.com/novi-file-uploads/nhms/structure/favicon-1.ico)

## Summary
Oral semaglutide significantly reduces heart failure events in patients with type 2 diabetes, according to recent findings. This development offers new hope for managing cardiovascular risks in diabetic populations.

## Full Article
Welcome to the upgraded NHMS website! If you have not created your account on our new site, use this link to activate your account. Or click on the JOIN button at the top right corner. Once you have created an account, next time you visit you can click LOGIN.

ACKNOWLEDGE

---

*Content scraped from public sources with attribution. Users assume all risk.*  
*Auto-generated by [Perplexity News Tracker](https://github.com/myidkd1-coder/perplexity-news-tracker)*